Decoy Therapeutics is trading at $4.03 (down 20%), extending a multi-day slide from last week with no fresh, company-specific news identified as a clear driver.
- The decline appears idiosyncratic as broader U.S. equity indices are trading moderately higher, suggesting the move is not part of a sector or market-wide selloff.
- The price action may reflect ongoing volatility and profit-taking typical of a thinly traded micro-cap biotech name.